IOBT
IO Biotech Inc
NASDAQ: IOBT · HEALTHCARE · BIOTECHNOLOGY
$0.05
+0.00% today
Updated 2026-04-07
Market cap
$2.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$0 – $3
Volume
14.5M
IO Biotech Inc (IOBT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — |
| Cost of revenue | — | — | — | $540000.00 | $756000.00 | $849000.00 |
| Gross profit | — | — | — | $-540000.00 | $-756000.00 | $-849000.00 |
| Gross margin | — | — | — | — | — | — |
| R&D | $7.94M | $8.46M | $30.15M | $46.99M | $67.83M | $71.48M |
| SG&A | $1.98M | $1.68M | $11.08M | $24.44M | $23.61M | $23.69M |
| Operating income | $-9.91M | $-10.14M | $-41.23M | $-71.42M | $-91.44M | $-95.18M |
| Operating margin | — | — | — | — | — | — |
| EBITDA | $-824000.00 | $-12.02M | $-67.45M | $-69.34M | $-84.47M | $-93.20M |
| EBITDA margin | — | — | — | — | — | — |
| EBIT | $-10.74M | $-22.27M | $-67.45M | $-69.88M | $-85.23M | $-94.05M |
| Interest expense | $6000.00 | $26000.00 | $361000.00 | $302000.00 | $3000.00 | — |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-10.75M | $-12.04M | $-67.88M | $-71.46M | $-86.08M | $-95.49M |
| Net income growth (YoY) | — | -12.0% | -463.7% | -5.3% | -20.5% | -10.9% |
| Profit margin | — | — | — | — | — | — |